Effect of an α1-adrenergic blocker on plasticity elicited by motor training

Experimental Brain Research

Volumn 148, Issue 4, 2003, Pages 504-508

  Sawaki, L ^a   Werhahn, K J ^a   Barco, R ^a   Kopylev, L ^a   Cohen, L G ^a,b  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Learning; Motor training; Plasticity; Stroke; Transcranial magnetic stimulation

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; PRAZOSIN; PROPRANOLOL;

ADULT; ARTICLE; BRAIN CORTEX LESION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVALESCENCE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; MALE; MOTOR PERFORMANCE; NERVE CELL PLASTICITY; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REHABILITATION MEDICINE; STROKE; TRAINING;

EID: 0037325524     PISSN: 00144819     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00221-002-1328-x     Document Type: Article

References (15)

1. Akduman B, Crawford ED (2001) Terazosin, doxazosin, and prazosin: current clinical experience. Urology 58:49-54
2. Butefisch CM, Davis BC, Wise SP, Sawaki L, Kopylev L, Classen J, Cohen LG (2000) Mechanisms of use-dependent plasticity in the human motor cortex. Proc Natl Acad Sci USA 97:3661-3665
3. Butefisch CM, Davis BC, Sawaki L, Waldvogel D, Classen J, Kopylev L, Cohen LG (2002) Modulation of use-dependent plasticity by d-amphetamine. Ann Neurol 51:59-68
4. Classen J, Liepert J, Wise SP, Hallett M, Cohen LG (1998) Rapid plasticity of human cortical movement representation induced by practice. J Neurophysiol 79:1117-1123
5. Ebbs D (2001) A comparison of selected antihypertensives and the use of conventional vs ambulatory blood pressure in the detection and treatment of hypertension. Cardiology 96:3-9
6. Feeney DM, Westerberg VS (1990) Norepinephrine and brain damage: α noradrenergic pharmacology alters functional recovery after cortical trauma. Can J Psychol 44:233-252
7. Feeney DM, Weisend MP, Kline AE (1993) Noradrenergic pharmacotherapy, intracerebral infusion and adrenal transplantation promote functional recovery after cortical damage. J Neural Transplant Plast 4:199-213
8. Goldstein LB (2000) Effects of amphetamines and small related molecules on recovery after stroke in animals and man. Neuropharmacology 39:852-859
9. Goldstein LB, Dromerick AW, Good DC, Lennihan L, McDowell F, Reding MJ, Plains W, Samsa GP (2002) Possible time window for the detrimental effects of drugs on poststroke recovery. American Academy of Neurology 54th Annual Meeting Program 58:A5-A6
10. Hovda DA, Sutton RL, Feeney DM (1989) Amphetamine-induced recovery of visual cliff performance after bilateral visual cortex ablation in cats: measurements of depth perception thresholds. Behav Neurosci 103:574-584
11. Ikegaya Y, Nakanishi K, Saito H, Abe K (1997) Amygdala β-adrenergic influence on hippocampal long-term potentiation in vivo. Neuroreport 8:3143-3146
12. Inghilleri M, Berardelli A, Cruccu G, Manfredi M (1993) Silent period evoked by transcranial stimulation of the human cortex and cervicomedullary junction. J Physiol (Lond) 466:521-534
13. Izumi Y, Zorumski CF (1999) Norepinephrine promotes long-term potentiation in the adult rat hippocampus in vitro. Synapse 31:196-202
14. Karni A, Meyer G, Jezzard P, Adams MM, Turner R, Ungerleider LG (1995) Functional MRI evidence for adult motor cortex plasticity during motor skill learning. Nature 377:155-158
15. Kobayashi K, Kobayashi T (2001) Genetic evidence for noradrenergic control of long-term memory consolidation. Brain Dev 23 [Suppl 1]:S16-S23